Home LiteratureArticle Details
PMID: 3182457 Published · ppublish English Clinical Trial Comparative Study Controlled Clinical Trial Journal Article Randomized Controlled Trial

Ofloxacin compared with ciprofloxacin in the treatment of complicated lower urinary tract infections.

The Journal of antimicrobial chemotherapy ·Vol. 22 Suppl C ·1988-09-00 ·Pages 143-7

Kromann-Andersen B, Sommer P, Pers C, Larsen V, Rasmussen F

Abstract

In a double-blind, double-dummy study 61 patients with structural or functional abnormalities of the urinary tract and verified infection were treated for 7 days with ofloxacin 100 mg bd or ciprofloxacin 250 mg bd by mouth. Of 62 isolated strains none was resistant to ofloxacin or ciprofloxacin in vitro. Nineteen patients (63%) in both groups were free from infection ten days after therapy. Clinical resolution of symptoms occurred in 83% in the ofloxacin group and 68% in the ciprofloxacin group. Adverse reactions were reported in four patients (6.5%), two with skin rash, one with gastrointestinal disturbance and one with influenza-like symptoms. This study demonstrates that ofloxacin and ciprofloxacin are effective in the treatment of complicated lower urinary tract infection.

MeSH Terms
Ciprofloxacin/adverse effects,therapeutic use Double-Blind Method Humans Ofloxacin/adverse effects,therapeutic use Prospective Studies Random Allocation Urinary Tract Infections/complications,drug therapy
Chemicals
Ciprofloxacin Ofloxacin
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Kromann-Andersen B
Department of Urology, Herlev Hospital, University of Copenhagen, Denmark.
Sommer P
Pers C
Larsen V
Rasmussen F
Article Info
Journal
The Journal of antimicrobial chemotherapy
Abbr.
J Antimicrob Chemother
ISSN
0305-7453
Published
1988-09-00
Pages
143-7
Language
English
Region
England
NLM ID
7513617
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]